Wound Infections Clinical Trial
Official title:
Cubicin(R) for Complicated Post-surgical Wound Infections
The purpose of the study is to describe the clinical efficacy of CUBICIN therapy in patients with superficial and deep post-surgical Gram-positive wound infections
A multi-center, single-arm, open-label, non-comparative study to describe the clinical efficacy of CUBICIN therapy in patients with superficial and deep post-surgical Gram-positive wound infections. Adjunctive treatment with aztreonam and/or metronidazole could be given for Gram-negative and/or anaerobic organisms. Patients are to be treated for a period of 7-14 days as specified in the package insert. An evaluation is to be performed on the day CUBICIN treatment is completed (assessment for outcome of cure, improved, failure or unable to evaluate). A follow-up is required for patients with an Investigator response of 'Improved' at the end of treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01220700 -
Antimicrobial Coated Sutures in Paediatric Surgery
|
N/A | |
| Completed |
NCT02578745 -
Prophylactic Incisional Care in Obese Women at Cesarean
|
N/A | |
| Withdrawn |
NCT00463762 -
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
|
Phase 4 | |
| Completed |
NCT00061633 -
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
|
Phase 2 | |
| Completed |
NCT01700803 -
Povidone Iodine and Cesarean Section Wound Infections
|
Phase 3 | |
| Completed |
NCT01049971 -
REDWIL: Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors
|
N/A |